No significant effect of angiotensin II receptor blockade on intermediate cardiovascular end points in hemodialysis patients

Autor: Peters, Christian D. ^*, Kjaergaard, Krista D., Jensen, Jens D., Christensen, Kent L., Strandhave, Charlotte, Tietze, Ida N., Novosel, Marija K., Bibby, Bo M., Jensen, Lars T., Sloth, Erik, Jespersen, Bente

Publikováno v: In Kidney International September 2014 86(3):625-637

Angiotensin II receptor blockade does not protect against progressive loss of residual renal function in hemodialysis patients: A randomized controlled trial (SAFIR study)

Autor: Krista Dybtved Kjærgaard, Christian Daugaard Peters, Bente Jespersen, Tietze, Ida N., Jens Kristian Madsen, Birgitte Bang Pedersen, Novosel, Marija K., Kathrine Skaaning Laursen, Bo Martin Bibby, Charlotte Strandhave, Jens Dam Jensen

Publikováno v: Kjærgaard, K D, Peters, C D, Jespersen, B, Tietze, I N, Madsen, J K, Pedersen, B B, Novosel, M K, Laursen, K S, Bibby, B M, Strandhave, C & Jensen, J D 2014, ' Angiotensin II receptor blockade does not protect against progressive loss of residual renal function in hemodialysis patients: A randomized controlled trial (SAFIR study) ', Aarhus, Denmark, 02/05/2014-03/05/2014, .
Aarhus University

Background: Glomerular filtration rate (GFR) declines during chronic dialysis treatment. In peritoneal dialysis, blockade of the renin-angiotensin-aldosterone system reduces GFR decline. Observational studies suggest that similar treatment may preser

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::3852f68fa21a2c55ef1b67127f047e19
https://pure.au.dk/portal/da/publications/angiotensin-ii-receptor-blockade-does-not-protect-against-progressive-loss-of-residual-renal-function-in-hemodialysis-patients-a-randomized-controlled-trial-safir-study(1aa523b5-0cac-4a9f-b32a-b80c5f21b826).html

Impaired renal haemodynamic response to amino acid infusion in essential hypertension during angiotensin converting enzyme inhibitor treatment

Autor: Tietze, Ida N., Sørensen, Søren S., Ivarsen, Per R., Nielsen, Claus B., Pedersen, Erling B.

Publikováno v: Journal of Hypertension; May 1997, Vol. 15 Issue: 5 p551-560, 10p

Effects of angiotensin II blockade on intermediate cardiovascular endpoints in haemodialysis patients: a randomised double-blind placebo-controlled one-year intervention trial (SAFIR study)

Autor: Christian Daugaard Peters, Krista Dybtved Kjærgaard, Jens Dam Jensen, Kent Lodberg Christensen, Charlotte Strandhave, Tietze, Ida N., Novosel, Marija K., Bo Martin Bibby, Lars Thorbjørn Jensen, Erik Sloth, Bente Jespersen

Publikováno v: Aarhus University
Peters, C D, Kjærgaard, K D, Jensen, J D, Christensen, K L, Strandhave, C, Tietze, I N, Novosel, M K, Bibby, B M, Jensen, L T, Sloth, E & Jespersen, B 2014, ' Effects of angiotensin II blockade on intermediate cardiovascular endpoints in haemodialysis patients: a randomised double-blind placebo-controlled one-year intervention trial (SAFIR study) ', Korsør, Denmark, 25/04/2014-26/05/2014, .

Agents blocking the renin-angiotensin-aldosterone system are frequently used in end-stage renal disease patients, but whether they exert beneficial cardiovascular (CV) effects is unclear. The long-term effects of the angiotensin II receptor blocker i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1ac3c17c0068676e0524d3ff3b9546b3
https://pure.au.dk/portal/en/publications/effects-of-angiotensin-ii-blockade-on-intermediate-cardiovascular-endpoints-in-haemodialysis-patients-a-randomised-doubleblind-placebocontrolled-oneyear-intervention-trial-safir-study(bcc4c5e0-6cf7-4fb8-964f-4c0c5dd13cdd).html